The frequency of Helicobacter pylori infection in the lesion of esophagogastroduodenal zone in patients with spinal osteochondrosis
DOI:
https://doi.org/10.32782/2415-8127.2024.69.7Keywords:
osteochondrosis of the lumbar spine, lesions of the esophagogastroduodenal zone (gastroesophageal reflux disease, chronic gastritis, gastric and duodenal ulcers), Helicobacter pyloriAbstract
Introduction. An important component of the treatment of spinal degenerative disc disease (DDD) is the prevention of degenerative processes in articular cartilage, reduction of pain and inflammation. Current guidelines recommend testing and treating H. pylori (HP) infection in patients taking NSAIDs who are at risk of upper gastrointestinal bleeding. The purpose of the study: to determine the frequency of Helicobacter pylori (HP) infection in the lesion of esophagogastroduodenal zone (EGDZ) in patients with osteochondrosis (OC of the lumbar spine). Object and research methods. We examined 226 patients with OC of the lumbar spine and EGDZ lesions. Patients were divided into three groups, depending on the endoscopic findings of upper gastrointestinal tract lesions: group I included patients with gastroesophageal reflux disease (GERD) (n=78); group II included patients with chronic gastritis (CG) (n=102); group III included patients with gastric ulcer (GU) and duodenal ulcer (DU) (n=46). All examined patients were diagnosed with HP infection. Research results and their discussion. A high incidence of HP infection in patients with EGDZ and OC of the lumbar spine was found (88.9 % of patients). At the same time, HP infection was diagnosed more often in patients of group III (with gastric and duodenal ulcers) – 95.7 % of cases, as well as in patients of group II with CG – 90.2 % of the examined. In patients of group I with GERD and OC of the lumbar spine, HP was diagnosed in only 83.3 % of patients (p<0.05). According to the results obtained, regardless of the form of EGDZ lesions in the examined patients with OC of the lumbar spine, clinically, EGDZ lesions are more pronounced in the case of persistent HP infection. Conclusions. 1. A high incidence of HP infection (88.9 % of cases) was found in patients with OC of the lumbar spine and EGDZ lesions, with these patients being mainly those with gastric and duodenal ulcers (95.7 % of cases). 2. In HP-positive patients with OC of the lumbar spine and EGDZ lesions, clinical symptoms are more pronounced regardless of the form of upper gastrointestinal lesions, manifested by heartburn, acid belching, pain and heaviness in the epigastric region, as well as periodic nausea and vomiting against a background of decreased appetite.
References
Valetska R, Petryk O. Osteokhondroz, profilaktyka, zastosuvannia likuvalnoi fizychnoi kultury. Fizychne vykhovannia, sport i kultura zdorovia u suchasnomu suspilstvi. 2015; 4 (32): 145–150.
Svyrydova NK, Sereda VH, Popov OV, Pavliuk NP, Usovych KM, Svystun VIu. Deheneratyvno-dystrofichni zakhvoriuvannia khrebta: osoblyvosti diahnostyky ta likuvannia. Skhidno-yevropeiskyi zhurnal po nevrolohii. 2015; 02 (02): 15–26.
Babinets LS, Halabitska IM. Otsiniuvannia pankreatotropnoi i suhlobovoi efektyvnosti vnutrishnoklitynnoho systemnoho enzymu pry osteoartrozi. Simeina medytsyna. 2020; 5-6 (91-92): 66-69.
Gossec L, Baraliakos X, Kerschbaumer A et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis. 2020 Jun;79(6):700-712. doi: 10.1136/annrheumdis-2020-217159. PMID: 32434812; PMCID: PMC7286048.
Qaseem A, Wilt TJ, McLean RM et al. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017 Apr 4; 166 (7):514-530.
Côté P, Wong JJ, Sutton D et al. Management of neck pain and associated disorders: A clinical practice guideline from the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur Spine J. 2016 Jul; 25 (7): 2000–2022.
Sohail R, Mathew M, Patel K K, et al. (April 03, 2023) Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review. Cureus 15(4): e37080.
Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020 Oct; 180: 114147.
Chi TY, Zhu HM, Zhang M. Risk factors associated with nonsteroidal anti-inflammatory drugs (NSAIDs)-induced gastrointestinal bleeding resulting on people over 60 years old in Beijing. Medicine (Baltimore). 2018 May; 97 (18): e0665.
Houston KV, Patel A, Saadeh M, Vargas A, D’Souza SM, Yoo BS et al. Gаstroesophageal Reflux Disease: A Potentially Infectious Disease? J Transl Gastroen. 2023; 1 (1): 30–39.